Hjem › Kreft (alle typer) › New Mexico › Albuquerque
Kliniske studier for Kreft (alle typer) i Albuquerque, NM
14 studier for Kreft (alle typer) søker deltakere på steder i og rundt Albuquerque (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekruttererFase 3
- University of New Mexico Cancer Center, Albuquerque
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- University of New Mexico, School of Medicine, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruttererFase 1/2
- Research Site, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- University of New Mexico Cancer Center, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 292, Albuquerque
Molecular Genetics Studies of Cancer Patients and Their Relatives
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Rekrutterer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Albuquerque
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- New Mexico Oncology Hematology Consultants, Albuquerque
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RekruttererObservasjonsstudie
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Albuquerque
- Ikke-småcellet lungekreft18 studier
- Brystkreft17 studier
- Eggstokkreft15 studier
- Lungekreft14 studier
- Metastatisk kreft12 studier
- Endometriekreft12 studier
- Type 2-diabetes11 studier
- Kardiovaskulær sykdom10 studier
- Melanom9 studier
- Akut myelogen leukemi9 studier
- Prostatakreft9 studier
- Kronisk nyresykdom8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.